Persistence of virologic response after liver transplant in hepatitis C patients treated with ledipasvir/sofosbuvir plus ribavirin pretransplant | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Persistence of virologic response after liver transplant in hepatitis C patients treated with ledipasvir/sofosbuvir plus ribavirin pretransplant

Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, et al. Persistence of virologic response after liver transplant in hepatitis C patients treated with ledipasvir/sofosbuvir plus ribavirin pretransplant. Ann Hepatol. 2017;16(3):375-381.

Publication Type:

Journal Article

Source:

Ann Hepatol, Volume 16, Issue 3, p.375-381 (2017)

Cited On:

Patients With Decompensated Cirrhosis

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/28425407

Export Citation:

RIS Format

Top